147 What are the main concerns of participants in a drug trial for chronic breathlessness? | BMJ Supportive & Palliative Care

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Poster presentations

Symptom Management | Posters 143 – 160

147 What are the main concerns of participants in a drug trial for chronic breathlessness?

Free

Authors

S Singh Cicely Saunders Institute, Department of Palliative Care, Policy and Rehabilitation, King’s College London PubMed articles Google scholar articles
N Lovell Cicely Saunders Institute, Department of Palliative Care, Policy and Rehabilitation, King’s College London PubMed articles Google scholar articles
D Yi Cicely Saunders Institute, Department of Palliative Care, Policy and Rehabilitation, King’s College London PubMed articles Google scholar articles
IJ Higginson Cicely Saunders Institute, Department of Palliative Care, Policy and Rehabilitation, King’s College London PubMed articles Google scholar articles

Citation

Singh S, Lovell N, Yi D, et al

147 What are the main concerns of participants in a drug trial for chronic breathlessness?

BMJ Supportive & Palliative Care 2019;9:A62.

Publication history

First published March 1, 2019.

Online issue publication

May 12, 2022

View clinical trial registration.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions